Literature DB >> 19071186

An avian cell line designed for production of highly attenuated viruses.

Ingo Jordan1, Ad Vos, Stefanie Beilfuss, Andreas Neubert, Sabine Breul, Volker Sandig.   

Abstract

Several viral vaccines, including highly promising vectors such as modified vaccinia Ankara (MVA), are produced on chicken embryo fibroblasts. Dependence on primary cells complicates production especially in large vaccination programs. With primary cells it is also not possible to create packaging lines for replication-deficient vectors that are adapted to proliferation in an avian host. To obviate requirement for primary cells permanent lines from specific tissues of muscovy duck were derived (AGE1.CR, CS, and CA) and further modified: we demonstrate that stable expression of the structural gene pIX from human adenovirus increases titers for unrelated poxvirus in the avian cells. This augmentation appears to be mediated via induction of heat shock and thus provides a novel cellular substrate that may allow further attenuation of vaccine strains.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19071186     DOI: 10.1016/j.vaccine.2008.11.066

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  29 in total

1.  Quantitative characterization of metabolism and metabolic shifts during growth of the new human cell line AGE1.HN using time resolved metabolic flux analysis.

Authors:  Jens Niklas; Eva Schräder; Volker Sandig; Thomas Noll; Elmar Heinzle
Journal:  Bioprocess Biosyst Eng       Date:  2010-12-25       Impact factor: 3.210

Review 2.  Vaccines: the fourth century.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2009-09-30

Review 3.  Cell culture-based influenza vaccines: A necessary and indispensable investment for the future.

Authors:  Nagendra R Hegde
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Highly efficient, chemically defined and fully scalable biphasic production of vaccine viruses.

Authors:  Ingo Jordan; Volker Sandig
Journal:  BMC Proc       Date:  2011-11-22

5.  Animal Cell Expression Systems.

Authors:  M Butler; U Reichl
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

6.  Attenuation and immunogenicity of host-range extended modified vaccinia virus Ankara recombinants.

Authors:  Sharon Melamed; Linda S Wyatt; Robin J Kastenmayer; Bernard Moss
Journal:  Vaccine       Date:  2013-08-06       Impact factor: 3.641

7.  Authentication of the R06E fruit bat cell line.

Authors:  Ingo Jordan; Vincent J Munster; Volker Sandig
Journal:  Viruses       Date:  2012-05-23       Impact factor: 5.048

8.  Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells.

Authors:  Verena Lohr; Yvonne Genzel; Ingo Jordan; Dietmar Katinger; Stefan Mahr; Volker Sandig; Udo Reichl
Journal:  BMC Biotechnol       Date:  2012-10-30       Impact factor: 2.563

9.  Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles.

Authors:  Timo Frensing; Frank Stefan Heldt; Antje Pflugmacher; Ilona Behrendt; Ingo Jordan; Dietrich Flockerzi; Yvonne Genzel; Udo Reichl
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

10.  A genotype of modified vaccinia Ankara (MVA) that facilitates replication in suspension cultures in chemically defined medium.

Authors:  Ingo Jordan; Deborah Horn; Katrin John; Volker Sandig
Journal:  Viruses       Date:  2013-01-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.